References

1. Edwards J., McGorry P.D. (2002). Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services. Dunitz, London.

2. Birchwood M., Macmillan J.F. (1993). Early intervention in schizophrenia. Aust. N. Zeal. J. Psychiatry, 27, 374-378.

3. Kulkarni J., Power P. (1999). Initial treatment of first-episode psychosis. In: McGorry P.D., Jackson H.J. (eds) The Recognition and Management of Early Psychosis. A Preventive Approach. Cambridge University Press, Cambridge, pp. 184-205.

4. Bottlender R., Moller H.J. (2003). The impact of the duration of untreated psychosis on short- and long-term outcome in schizophrenia. Curr. Opin. Psychiatry, 16 (Suppl. 2), S39-S43.

5. Garety P., Jolley S. (2000). Early intervention in psychosis. Psychiatr. Bull., 24, 321-323.

6. McGorry P.D., Chanen A., McCarthy E., Van Riel R., McKenzie D., Singh B.S. (1991). Posttraumatic stress disorder following recent-onset psychosis. An unrecognised post-psychotic syndrome. J. Nerv. Ment. Dis., 179, 253-258.

7. McGorry P.D. (1995). A treatment-relevant classification of psychotic disorders. Aust. N. Zeal. J. Psychiatry, 29, 555-558.

8. Birchwood M., Fowler D., Jackson C. (eds) (2000). Early Intervention in Psychosis: A Guide to Concepts, Evidence and Intervention. John Wiley & Sons Ltd, Chichester.

9. McGorry P.D. (1994). The influence of illness duration on syndrome clarity and stability in functional psychosis: does the diagnosis emerge and stabilise with time? Aust. N. Zeal. J. Psychiatry, 28, 607-619.

10. Yung A.R., McGorry P.D. (1996). The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. N. Zeal. J. Psychiatry, 30, 587-599.

11. American Psychiatric Association (1997). Practice Guidelines for the Treatment of Patients with Schizophrenia. American Psychiatric Association, Washington, DC.

12. Jarry M., Andrews G., Hunt C. (1997). Management of Mental Disorders, World Health Organization Treatment Protocol Project, 2nd edn. World Health Organization Collaborating Centre for Mental Health and Substance Abuse, Darlinghurst, NSW.

13. Norman R.M.G., Malla A.K. (2001). Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol. Med., 31, 381-400.

14. National Institute for Clinical Excellence (NICE) (2002). Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Clinical Guideline 1. NICE, National Collaborating Centre for Mental Health, London.

15. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., Dube K.C., Ganev K., Giel R., van der Heiden W., et al. (2001). Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br. J. Psychiatry, 178, 506-517.

16. Meares A. (1959). The diagnosis of prepsychotic schizophrenia. Lancet, i, 55-59.

17. Sullivan H.S. (1927). The onset of schizophrenia. Am. J. Psychiatry, 6, 105-134.

18. Yung A.R., Phillips L.J., McGorry P.D., Hallgren M.A., McFarlane C.A., Jackson H.J., Francey S., Patton G.C. (1998). Can we predict onset of first episode psychosis in a high-risk group? Int. Clin. Psychopharmacol., 13 (Suppl. 1), S23-30.

19. Yung A.R., Phillips L.J., Yuen H.P., Francey S.M., McFarlane C.A., Hallgren M., McGorry P.D. (2003). Psychosis prediction: 12 month follow up of a high risk ("prodromal") group. Schizophr. Res., 60, 21-32.

20. Jones P., Rodgers B., Murray R., Marmot M. (1994). Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398-1402.

21. Hafner H., Nowotny B., Loffler W., an der Heiden W., Maurer K. (1995). When and how does schizophrenia produce social deficits? Eur. Arch. Psychiatry Clin. Neurosci., 246, 17-28.

22. Phillips L.J., Yung A.R., Yuen H.P., Pantelis C., McGorry P.D. (2002). Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am. J. Med. Genet., 114, 929-937.

23. Bell R.Q. (1992). Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry, 55, 370381.

24. Yung A.R., McGorry P.D., McFarlane C.A., Patton G.C. (1995). The PACE clinic: development of a clinical service for young people at high risk of psychosis. Australas. Psychiatry, 3, 345-349.

25. Cornblatt B., Lencz T., Correll C., Authour A., Smith C. (2002). Treating the prodrome: naturalistic findings from the RAP Program. Acta Psychiatr. Scand., 106 (Suppl. 413), 44.

26. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., Woods S.W. (2002). Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured interview for Prodromal Symptoms: preliminary evidence of interrater and predictive validity. Am. J. Psychiatry, 159, 863-865.

27. Morrison A.P., Bentall R.P., French P., Walford L., Kilcommons A., Knight A., Kreutz M., Lewis S.W. (2002). Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. Br. J. Psychiatry, 181 (Suppl. 43), s78-s84.

28. McGorry P.D., Singh B.S. (1995). Schizophrenia: risk and possibility. In: Raphael B., Burrows G.D. (eds) Handbook of Studies on Preventive Psychiatry. Elsevier, Amsterdam, pp. 491-514.

29. Yung A.R., McGorry P.D. (1997). Is pre-psychotic intervention realistic in schizophrenia and related disorders? Aust. N. Zeal. J. Psychiatry, 31, 799-805.

30. Eaton W.W., Badawi M., Melton B. (1995). Prodromes and precursors: epidemiological data for primary prevention of disorders with slow onset. Am. J. Psychiatry, 152, 967-972.

31. Larsen T.K., Friis S., Haahr U., Joa I., Johannessen J.O., Melle I., Opjordsmoen S., Simonsen E., Vaglum P. (2001). Early detection and intervention in firstepisode schizophrenia: a critical review. Acta Psychiatr. Scand., 103, 323-334.

32. McGorry P.D., Yung A.R., Phillips L.J., Yuen H.P., Francey S., Cosgrave E.M., Germano D., Bravin J., Adlard S., McDonald T., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry, 59, 921-928.

33. Miller T.J., Zipursky R.B., Perkins D., Addington J., Woods S.W., Hawkins K.A., Hoffman R., Preda A., Epstein I., Addington D., et al. (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr. Res., 61, 19-30.

34. Wyatt R.J. (1991). Neuroleptics and the natural course of schizophrenia. Schizophr. Bull., 17, 325-351.

35. Ho B.-C., Alicate D., Ward J., Moser D.J., O'Leary D.S., Arndt S., Andreasen N.C. (2003). Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am. J. Psychiatry, 160, 142-148.

36. McGorry P.D. (1992). The concept of recovery and secondary prevention in psychotic disorders. Aust. N. Zeal. J. Psychiatry, 26, 3-17.

37. McGorry P.D., Edwards J., Mihalopoulos C., Harrigan S., Jackson H.J. (1996). The Early Psychosis Prevention and Intervention Centre (EPPIC): an evolving system of early detection and optimal management. Schizophr. Bull., 22, 305326.

38. McGorry P.D., Yung A.R. (2003). Early intervention in psychosis: an overdue reform: An introduction to the Early Psychosis Symposium. Aust. N. Zeal. J. Psychiatry, 37, 393-398.

39. Lincoln C., McGorry P.D. (1999). Pathways to care in early psychosis: delay and decline? In: McGorry P.D., Jackson J.J. (eds) The Recognition and Management of Early Psychosis: A Preventive Approach. Cambridge University Press, New York, pp. 51-80.

40. Skeate A., Jackson C., Birchwood M., Jones C. (2002). Duration of untreated psychosis and pathways to care in first-episode psychosis. Br. J. Psychiatry, 181, s73-s77.

41. McGorry P.D., Killackey E., Elkins K., Lambert M., Lamter T. (2003). Summary Australian and New Zealand clinical practice guideline for the treatment of schizophrenia (2003). Australas. Psychiatry, 11, 136-147.

42. Power P., McGorry P.D. (1999). Initial assessment of first-episode psychosis. In: McGorry P.D., Jackson H.J. (eds) The Recognition and Management of Early Psychosis. A Preventive Approach. Cambridge University Press, Cambridge, pp. 155-183.

43. Yung A.R., Phillips L.J., Drew L.T. (1999). Promoting access to care in early psychosis. In: McGorry P.D., Jackson H.J. (eds) The Recognition and Management of Early Psychosis. A Preventive Approach. Cambridge University Press, Cambridge, pp. 81-114.

44. McGorry P.D., Yung A.R., Phillips L.J., Cadenhead K., Sharma T. (in press). Clinical service models for intervention in the prepsychotic phase: towards effective and safe strategies for earliest intervention in psychotic disorders. Schizophr. Bull.

45. McGorry P.D., McConville S.B. (1999). Insight in psychosis: an elusive target. Compr. Psychiatry, 40, 131-142.

46. Power P., Elkins K., Adlard S., Curry C., McGorry P., Harrigan S. (1998). An analysis of initial treatment of first episode psychosis. Br. J. Psychiatry, 172 (Suppl. 33), 71-76.

47. Strakowski S.M., Tohen M., Stoll A., Faedda G.L., Mayer P.V., Kolbrener M.L., Goodwin D.C. (1993). Comorbidity in psychosis at first hospitalisation. Am. J. Psychiatry, 150, 752-757.

48. Humphries M.S., Johnstone E.C., Macmillan J.F., Taylor P.J. (1992). Dangerous behaviour preceding first admissions for schizophrenia. Br. J. Psychiatry, 161, 501-505.

49. NSW Health, Centre for Mental Health (2002). Mental Health for Emergency Departments - A Reference Guide Pocket Version. NSW Health, Sydney.

50. Lubman D.I., Velakoulis D., McGorry P.D., Smith D.J., Brewer W., Stuart G., Desmond P., Tress B., Pantelis C. (2002). Incidental radiological findings on brain magnetic resonance imaging in first-episode psychosis and chronic schizophrenia. Acta Psychiatr. Scand., 106, 331-336.

51. Loebel A.D., Leiberman J.A., Alvir J.M.J., Mayerhoff D.I., Geisler S.H., Szymansky S.R. (1992). Duration of psychosis outcome in first episode schizophrenia. Am. J. Psychiatry, 149, 1183-1188.

52. McEvoy J.P., Hogarty G.E., Steingard S. (1991). Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Arch. Gen. Psychiatry, 48, 739-745.

53. Merlo M.C.G., Hofer H., Gekle W., Berger G., Ventura J., Panhuber I., Latour G., Marder S.R. (2002). Risperidone, 2mg/day vs. 4 mg/day, in first-episode, acutely psychotic patients: treatment efficacy and effects on fine motor functioning. J. Clin. Psychiatry, 63, 885-891.

54. Lieberman J.A., Tollefson G., Tohen M., Green A.I., Gur R.E., Kahn R., McEvoy J., Perkins D., Sharma T., Zipursky R., et al. (2003). Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am. J. Psychiatry, 160, 1396-1404.

55. Kapur S., Zipursky R., Jones C., Remington G., Houle S. (2000). Relationship between dopamine D2 occupancy, clinical response, and side effects: a doubleblind PET study of first-episode schizophrenia. Am. J. Psychiatry, 157, 514-520.

56. National Early Psychosis Project Clinical Guidelines Working Party (1998). Australian Clinical Guidelines for Early Psychosis. National Early Psychosis Project, University of Melbourne, Melbourne.

57. Davis J.M., Chen N., Glick I.D. (2003). A meta-analysis of the efficacy of second-generation antipsychotics. Arch. Gen. Psychiatry, 60, 553-564.

58. Nose M., Barbui C., Tansella M. (2003). How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol. Med., 33, 1149-1160.

59. Geddes J., Freemantle N., Harrison P., Bebbington P. (2000). Atypical anti-psychotics in the treatment of schizophrenia: systematic overview and metaregression analysis. Br. Med. J., 321, 1371-1376.

60. Stroup T.S., McEvoy J.P., Swartz M.S., Byerly M.J., Glick I.D., Canive J.M., McGee M.F., Simpson G.M., Stevens M.C., Lieberman J.A. (2003). The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr. Bull, 29, 15-31.

61. Garety P.A., Fowler D., Kuipers E. (2000). Cognitive-behavioral therapy for medication-resistant symptoms. Schizophr. Bull., 26, 73-86.

62. Robinson D.G., Woerner M.G., Alvir J.M.A., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., Bilder R., Goldman R. et al. (1999). Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry, 56, 241-247.

63. Gitlin M., Nuechterlein K., Subotnik K.L., Ventura J., Mintz J., Fogelson D.L., Bartzokis G., Aravagiri M. (2001). Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am. J. Psychiatry, 158, 1835-1842.

64. Carpenter W.T. (2001). Evidence-based treatment for first-episode schizophrenia? Am. J. Psychiatry, 158, 1771-1773.

65. Gleeson J., Jackson H.J., Stavely H., Burnett P. (1999). Family intervention in early psychosis. In: McGorry P.D., Jackson H.J. (eds) The Recognition and Management of Early Psychosis. Cambridge University Press, New York, pp. 376406.

66. Aitchison K.J., Meehan K., Murray R.M. (1999). First Episode Psychosis. Dunitz, London.

67. Gleeson J.F.M., McGorry P.D. (2004). Psychological Interventions in Early Psychosis: A Treatment Handbook. John Wiley & Sons Ltd, Chichester.

68. Lewis S., Tarrier N., Haddock G., Bentall R., Kinderman P., Kingdon D., Siddle R., Drake R., Everitt J., Leadley K., et al. (2002). Randomised controlled trial of cognitive-behaviour therapy in early schizophrenia: acute-phase outcomes. Br. J. Psychiatry, 181 (Suppl. 43), s91-s97.

69. Jackson H.J., McGorry P.D., Edwards J., Hulbert C., Henry L., Francey S., Cocks J., Power P., Harrigan S., Dudgeon P. (1998). Cognitively oriented psychotherapy for early psychosis (COPE): preliminary results. Br. J. Psychiatry, 172 (Suppl. 33), 93-100.

70. Power P.J.R., Bell R.J., Mills R., Herrman-Doig T., Davern M., Henry L., Yuen H.P., Khademy-Deljo A., McGorry P.D. (2003). Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis. Aust. N. Zeal. J. Psychiatry, 37, 414-420.

71. Edwards J., Maude D., Herrman-Doig T., Wong L., Cocks J., Burnett P., Bennett C., Wade D., McGorry P. (2002). A service response to prolonged recovery in early psychosis. Psychiatr. Serv., 53, 1067-1069.

72. Kulkarni J. (1999). Home-based treatment of first-episode psychosis. In: McGorry P.D., Jackson H.J. (eds) The Recognition and Management of Early Psychosis. A Preventive Approach. Cambridge University Press, Cambridge, pp. 206-225.

73. Fitzgerald P., Kulkarni J. (1998). Home-oriented management program for people with early psychosis. Br. J. Psychiatry, 172 (Suppl. 33), 39-44.

74. Joy C.B., Adams C.E., Rice K. (2000). Crisis intervention for people with severe mental illness. Cochrane Database Systematic Reviews, 2, CS001087.

75. Bola J.R., Mosher L.R. (2002). At issue: predicting drug-free treatment response in acute psychosis from the Soteria project. Schizophr. Bull., 28, 559-575.

76. Farrell G.A., Dares G. (1996). Seclusion or solitary confinement: therapeutic or punitive treatment? Aust. N. Zeal. J. Ment. Health Nursing, 5, 171-179.

Living Life

Living Life

Want to be and stay positive? Download This Guide And Discover 50 Tips To Have A Positive Outlook In Life. Finally! Reach your goals, face your fears and have a more fulfilled and happy life.

Get My Free Ebook


Post a comment